Last updated: August 17, 2026

Cord Blood Therapies
CLEVECORD (HPC Cord Blood)
CLEVELAND CORD BLOOD CENTER
Approved by the U.S. FDA in 2016 for use in unrelated donor hematopoietic progenitor cell transplantation procedures.

HPC Cord Blood
BLOODWORKS
Approved by the U.S. FDA in 2016 for use in unrelated donor hematopoietic progenitor cell transplantation procedures.

HPC Cord Blood
MD ANDERSON CORD BLOOD BANK
Approved by the U.S. FDA in June 2018 for use in unrelated donor hematopoietic progenitor cell transplantation procedures.

Hemacord (HPC Cord Blood)
NEW YORK BLOOD CENTER
Approved by the U.S. FDA in 2011 for use in unrelated donor hematopoietic progenitor cell transplantation procedures.

Allocord (HPC Cord Blood)
SSM CARDINAL GLENNON CHILDREN’S MEDICAL CENTER
Approved by the U.S. FDA in 2013 for use in unrelated donor hematopoietic progenitor cell transplantation procedures.

Ducord (HPC Cord Blood)
DUKE UNIVERSITY MEDICAL CENTER
Approved by the U.S. FDA in 2012 for use in unrelated donor hematopoietic progenitor cell transplantation procedures.

HPC Cord Blood
CLINIMMUNE
Approved by the U.S. FDA in 2012 for use in unrelated donor hematopoietic progenitor cell transplantation procedures.

HPC Cord Blood
LIFE SOUTH
Approved by the U.S. FDA in 2016 for use in unrelated donor hematopoietic progenitor cell transplantation procedures.

Scientific case review

Scientific Case Review

Would you like to understand whether current clinical programs, recent research developments, or emerging approaches may be relevant to your individual situation?

Share your question with our scientific research team and receive information focused on the areas of current research that may be relevant to your case.

  • Review of the information you provide
  • Relevant research and clinical program information
  • A clear response focused on your situation
What happens next? Send your question, receive a focused scientific review, and get a clear response about research and clinical programs relevant to your situation.
Your scientific review will be prepared by Dr. Helen Melnik, PhD , who has more than 25 years of experience in stem cell research and international clinical programs.

No obligation. Your question will be reviewed confidentially.

Educational and research information only. This service does not constitute medical advice, diagnosis, prescription, or a personalized treatment recommendation.


NBScience

contract research organization

WhatsApp